PG-102(MG12): Clinical Trials

1 trial of PG-102(MG12), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Not yet recruiting 1

Follow PG-102(MG12): new trials by email Literature Review of PG-102(MG12) trials Research Report on PG-102(MG12)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase II Study of Switching From Dulaglutide to PG-102(MG12) in Type 2 Diabetes Mellitus
PG-102(MG12), Dulaglutide - Type 2 Diabetes
Phase 2Not yet recruitingProGen. Co., Ltd.602026-10-012026-07-01

Conditions studied

Diabetes Mellitus, Type 2 (1)

Sponsors

ProGen. Co., Ltd. (1)